Tianlong Contributes to China’s Power to Prevent and Control Global Epidemics

By LabMedica International staff writers
Posted on 03 Jan 2023

Since the year 2003, Tianlong Science and Technology (Shaanxi, China) has witnessed several health crises globally and has also contributed to China’s power to prevent and control major epidemics such as COVID-19, SARS, Avian influenza, Ebola, Zika, and African swine fever.

Tianlong is an innovative high-tech company specializing in molecular diagnostic products. Since being founded in 1997, Tianlong has devoted itself to providing integrated PCR lab solutions for professionals worldwide. The company has a wide range of products from devices to reagents, including nucleic acid extractors, real-time PCR systems, all-in-one molecular diagnosis systems, sample processing systems, liquid handling systems, and 300 kinds of compatible reagents.

Image: Tianlong exports its products to more than 100 countries and regions worldwide (Photo courtesy of Tianlong)

With NMPA, CE, and FDA marks, Tianlong’s products are exported to more than 100 countries and regions worldwide, and have greatly helped in the prevention and control of epidemics such as COVID-19, SARS, Avian influenza, Ebola, Zika, and African swine fever. Tianlong continues to excel in R&D and bringing technology to life to make people's lives healthier and happier.

Related Links:
Tianlong Science and Technology